RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica Important Update on FDA Changes Concerning Peptides Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not